Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results
X
Xiuning Le
(Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA)
M
Mike Hernandez
S
Simon Heeke
A
Andreas Saltos
(Xiuning Le, MD, PhD, Mike Hernandez, MS, and Simon Heeke, PhD, UT MD Anderson Cancer Center, Houston, TX, Andreas Saltos, MD, Moffitt Cancer Center, FL and, John V. Heymach MD, PhD UT MD Anderson Cancer Center, Houston, TX)
J
John V. Heymach
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 13
Published
May 01, 2025
Pages
1613-1614
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (5)
X
Xiuning Le
Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA
M
Mike Hernandez
S
Simon Heeke
A
Andreas Saltos
Xiuning Le, MD, PhD, Mike Hernandez, MS, and Simon Heeke, PhD, UT MD Anderson Cancer Center, Houston, TX, Andreas Saltos, MD, Moffitt Cancer Center, FL and, John V. Heymach MD, PhD UT MD Anderson Cancer Center, Houston, TX
J
John V. Heymach
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001